Clinically™ reposted this
In a new open letter, EmpiRx Health CEO Danny S. addresses the bipartisan election year issue of skyrocketing drug costs. The PBM industry was founded more than a half-century ago to help manage these costs, but it has not exactly worked out that way. As legislators and regulators increasingly criticize the traditional volume-driven PBM operating model, there’s a growing drumbeat around PBM “transparency” as the solution to the massive problem of rising drug costs. But, as Sanchez notes in his open letter, “transparency is just one step” in the vital push for PBM reform. What’s really needed is the broader adoption of a clinically-driven approach to pharmacy care that puts the pharmacist back in pharmacy benefits management. Want to learn more about the clinically-driven PBM reform revolution? Read the entire open letter here: https://lnkd.in/eAAKtpJR #OpenLetter #PBM #Legislators #ClinicallyDriven